Inactief instrument

Andere talen Insys Therapeutics Inc Nasdaq

Aandelen

US45824V2097

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Special Fraud Alert: Speaker Programs – If It's Too Good To Be True, It Probably Is	27-11-20
INSYS Therapeutics, Inc.'s Equity Buyback announced on November 5, 2015, has expired.	31-03-20
INSYS Therapeutics, Inc. Went Out of Business	18-02-20
INSYS THERAPEUTICS, INC. : Other Events (form 8-K)	11-02-20
INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	10-02-20
Bankruptcy Judge Changed for INSYS Therapeutics, Inc.	06-02-20
INSYS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	05-02-20
Second Motion for Exclusivity Period Extension Approved For INSYS Therapeutics, Inc.	22-01-20
INSYS THERAPEUTICS, INC. : Regulation FD Disclosure (form 8-K)	17-01-20
Modified Second Amended Liquidation Plan Approved for INSYS Therapeutics, Inc.	16-01-20
INSYS Therapeutics : Ex-pharma exec sentenced to nearly 3 years in bribery scheme	14-01-20
INSYS Therapeutics : Ex-drug company execs face reckoning in opioid bribery case	12-01-20
INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	10-01-20
INSYS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	06-01-20
INSYS THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	26-12-19
Renaissance Lakewood, LLC completed the acquisition of certain assets of INSYS Therapeutics, Inc. (OTCPK:INSY.Q).	19-12-19
Motion for Asset Sale Approved for INSYS Therapeutics, Inc.	16-12-19
Second Amended Disclosure Statement Approved for INSYS Therapeutics, Inc.	04-12-19
INSYS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Changes in Registrant's Certifying Accountant, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	03-12-19
Renaissance Lakewood, LLC entered into an asset purchase agreement to acquire certain assets of INSYS Therapeutics, Inc. (OTCPK:INSY.Q) for $0.28 million.	03-12-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Insys Therapeutics Inc Nasdaq

Aandelen

US45824V2097

Andere talen

Filters